The United States Primary Biliary Cholangitis Market is driven by the availability of established and emerging treatment options, strong pharmaceutical research and development, and increasing access to specialized healthcare providers. Continued clinical research and advancements in targeted therapies are expected to improve treatment options and support disease management across the country....